|
| 36642631 | The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays. | Vaccine | 2023 |
| 37191544 | Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study. | Microbiol Spectr | 2023 |
| 37317810 | HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine. | Pediatrics | 2023 |
| 37384602 | The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays. | PLoS Pathog | 2023 |
| 37270364 | Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model. | Vaccine | 2023 |
| 37264688 | SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines. | Hum Vaccin Immunother | 2023 |
| 36927068 | Development, Validation, and Utilization of a Luminex-Based SARS-CoV-2 Multiplex Serology Assay. | Microbiol Spectr | 2023 |
| 34697062 | Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35804881 | Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability. | Cancers (Basel) | 2022 |
| 35351898 | HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial. | NPJ Vaccines | 2022 |
| 35703544 | The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. | mSphere | 2022 |
| 36173112 | Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. | mSphere | 2022 |
| 36358697 | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort. | Cancers (Basel) | 2022 |
| 36222529 | Selection, Characterization, Calibration, and Distribution of the U.S. Serology Standard for Anti-SARS-CoV-2 Antibody Detection. | J Clin Microbiol | 2022 |
| 36113532 | Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. | Lancet Glob Health | 2022 |
| 36113531 | Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. | Lancet Glob Health | 2022 |
| 34857420 | Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial. | Vaccine | 2022 |
| 35262095 | The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. | medRxiv | 2022 |
| 35019677 | A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays. | Microbiol Spectr | 2022 |
| 35017496 | molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history. | Nat Commun | 2022 |
| 33421649 | A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial. | Contemp Clin Trials | 2021 |
| 33574564 | Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer. | Sci Rep | 2021 |
| 33573433 | Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP. | Hum Vaccin Immunother | 2021 |
| 34782638 | Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. | Sci Rep | 2021 |
| 34183723 | Soluble cluster of differentiation 14 levels elevated in bile from gallbladder cancer cases from Shanghai, China. | Sci Rep | 2021 |
| 34286851 | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals. | Aliment Pharmacol Ther | 2021 |
| 34373120 | Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine. | Vaccine | 2021 |
| 32467351 | Metabolic Syndrome, Physical Activity, and Inflammation: A Cross-Sectional Analysis of 110 Circulating Biomarkers in Japanese Adults. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32100190 | Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease. | Cancer Causes Control | 2020 |
| 32042030 | Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. | Sci Rep | 2020 |
| 32105293 | Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. | JAMA Oncol | 2020 |
| 32091596 | Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial. | J Natl Cancer Inst | 2020 |
| 32091594 | Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial. | J Natl Cancer Inst | 2020 |
| 32713678 | Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. | Vaccine | 2020 |
| 30357905 | Circulating inflammation-related markers and advanced gastric premalignant lesions. | J Gastroenterol Hepatol | 2019 |
| 33336146 | A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor. | JNCI Cancer Spectr | 2019 |
| 30121626 | Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium. | Gut | 2019 |
| 31412122 | Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies. | J Infect Dis | 2019 |
| 31005426 | HPV-specific antibodies at the oral cavity up to 30⿯months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men. | Vaccine | 2019 |
| 30940485 | Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men. | Vaccine | 2019 |
| 30877129 | Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case-Cohort Study Within the Japan Public Health Center-Based Prospective Study. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 30753331 | Circulating inflammation markers and colorectal adenoma risk. | Carcinogenesis | 2019 |
| 30602499 | Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 28954299 | Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. | J Natl Cancer Inst | 2018 |
| 30132835 | Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan. | Int J Cancer | 2018 |
| 29554539 | Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. | Cancer Epidemiol | 2018 |
| 29475967 | An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 29361344 | Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development. | Vaccine | 2018 |
| 29671891 | Association of circulating inflammation proteins and gallstone disease. | J Gastroenterol Hepatol | 2018 |
| 29385144 | T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study. | PLoS One | 2018 |